Edwards Lifesciences | EW - Debt


Edwards Lifesciences reported $600M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 71.78M 1.6M Mar/2026
Baxter International USD 9.69B 93M Mar/2026
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Boston Scientific USD 11.03B 407M Mar/2026
Cooper Companies USD 2.5B 5.6M Dec/2025
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Globus Medical USD 115.22M 3.43M Mar/2026
ICU Medical USD 1.23B 94.6M Jun/2026
Inogen USD 0 0 Jun/2022
Insulet USD 948.4M 300K Jun/2026
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 54.99B 7.05B Mar/2026
Medtronic USD 27.96B 110M Mar/2026
Merit Medical Systems USD 821.56M 9K Mar/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 132.16M Jun/2026
Teleflex USD 2.69B 39.95M Mar/2026
Zimmer Biomet Holdings USD 7.48B 8M Jun/2026